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PYRETHROID INSECTICIDES: ISOFORM-DEPENDENT
HYDROLYSIS, INDUCTION OF CYTOCHROME P450 3A4 AND
EVIDENCE ON THE INVOLVEMENT OF THE PREGNANE X
RECEPTOR
Dongfang Yang, Xiliang Wang, Yi-tzai Chen, Ruitang Deng, and Bingfang Yan
Department of Biomedical and Pharmaceutical Sciences, Center for Pharmacogenomics and
Molecular Therapy, University of Rhode Island Kingston, RI 02881
Abstract
Pyrethroids account for more than one-third of the insecticides currently marketed in the world. In
mammals, these insecticides undergo extensive metabolism by carboxylesterases and cytochrome
P450s (CYPs). In addition, some pyrethroids are found to induce the expression of CYPs. The aim
of this study was to determine whether pyrethroids induce carboxylesterases and CYP3A4, and
whether the induction is correlated inversely with their hydrolysis. Human liver microsomes were
pooled and tested for the hydrolysis of 11 pyrethroids. All pyrethroids were hydrolyzed by the pooled
microsomes, but the hydrolytic rates varied by as many as 14 fold. Some pyrethroids such as
bioresmethrin were preferably hydrolyzed by carboxylesterase HCE1, whereas others such as
bifenthrin preferably by HCE2. In primary human hepatocytes, all pyrethroids except tetramethrin
significantly induced CYP3A4. In contrast, insignificant changes were detected on the expression
of carboxylesterases. The induction of CYP3A4 was confirmed in multiple cell lines including
HepG2, Hop92 and LS180. Overall, the magnitude of the induction was correlated inversely with
the rates of hydrolysis, but positively with the activation of the pregnane X receptor (PXR).
Transfection of a carboxylesterase markedly decreased the activation of PXR, and the decrease was
in agreement with carboxylesterase-based preference for hydrolysis. In addition, human PXR
variants as well as rat PXR differed from human PXR (wild-type) in responding to certain pyrethroids
(e.g., lambda-cyhalothrin), suggesting that induction of PXR target genes by these pyrethroids varies
depending on polymorphic variants and the PXR species identity.
INTRODUCTION
Pyrethroids constitute a major class of insecticides and account for more than one-third of the
insecticides currently marketed in the world (Dich et al., 1997; Casida and Quistad, 1998;
Adelsbach and Tjeerdema, 2003). In addition to crop and forestry protection, pyrethroid
insecticides are widely used for health programs such as parasite eradication and disinfection
of public facility (Heudorf and Angerer, 2001). There are two types of pyrethroids: type II
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compounds contain a cyano moiety in the α-position, whereas those without the cyano group
belong to type I pyrethroids. Introduction of the cyano moiety drastically increases the
insecticidal activity as well as lethal potency in rodents (Elliott, 1976; Soderlund and Knipple,
2003). In addition, type I and II pyrethroids cause distinct sets of symptoms after acute
poisoning. Type I pyrethroids induce sparring, whole-body tremor and prostration, whereas
type II pyrethroids induce burrowing, salivation, writhing and dermal tingling (Wolansky and
Harrill, 2008). In addition to acute poisoning, emerging experimental data suggest that many
pyrethroids during chronic exposure act as endocrine disruptors and even involve
carcinogenesis (Dich et al., 1997; Perry et al., 2007).
Pyrethroids, compared with other types of insecticides such as organophosphates, show higher
selectivity toward their intended species (i.e., insects) over non-intended species such as
mammals. In both insect and mammalian species, pyrethroids act on voltage-sensitive sodium
channels and exert neurotoxicity. However, the mammalian channels are much less sensitive
than their insect counterparts (Vais et al., 2001). In addition, mammalian species have a greater
metabolic capacity, leading to rapid elimination of exposed pyrethroids. Studies in rodents and
epidemiological data have shown that pyrethroids undergo extensive metabolism by
carboxylesterases and cytochrome P450s (CYPs) (Anand et al., 2006; Godin et al., 2006; Nishi
et al., 2006; Ross et al., 2006; Crow et al., 2007; Godin et al., 2007). Hydrolysis of pyrethroids
is generally considered a detoxication process (Casida et al., 1983; Cantalamessa, 1993). In
rats, pretreatment with tri-o-tolyl phosphate (a carboxylesterase inhibitor) significantly
increases the mortality of pyrethroids (Cantalamessa, 1993). The oxidative metabolism by
CYPs, on the other hand, may have opposite toxicological consequences depending on a
pyrethriod or even a test system. CYP inducers phenobarbital and 3-methylcholanthrene
potentiate deltamethrin (a pyrethriod) in the induction of neurobehavioral toxicity (Dayal et
al., 2003), whereas hepatoxicity of pyrethroid cypermethrin is markedly decreased in primary
hepatocytes pretreated by phenobarbital (EL-Tawil and Abdel-Rahman, 2001).
In addition to acting as CYP substrates, some pyrethroids are found to induce CYP enzymes.
In rat primary hepatocytes, cypermethrin significantly increases the activity of
ethoxyresorufin-O-deethylase, an indicator for CYP1A induction (Delescluse et Al., 1998). In
the same culturing system, permethrin induces CYP2B1 and CYP3A23 (Heder et al., 2001).
The induction even lasts from dam to offspring. In rats, prenatal exposure to deltamethrin
induces several major CYP enzymes and the induction persists postnatally up to 6–9 weeks
depending on the initial doses (Johri 2006). In addition to rat CYPs, a pyrethrum extract has
recently been shown to induce CYP enzymes in human hepatocytes (Price et al., 2008).
Cypermethrin and fenvelarate are potent activators of the pregnane X receptor (PXR), a master
regulator that supports induction of various types of drug-metabolizing enzymes including
CYP enzymes (Lemaire et al., 2004).
The aim of this study was to determine whether pyrethroids induce carboxylesterases and
CYP3A4, and whether the induction is correlated inversely with the hydrolysis of these
compounds. A panel of 11 pyrethroids (Table I, Fig. 1) was initially tested for hydrolysis by
pooled human liver microsomes. All pyrethroids were hydrolyzed, but the rates varied by as
many as 14 fold. Some pyrethroids were hydrolyzed preferably by carboxylesterase HCE1,
whereas others by HCE2. In primary human hepatocytes, all pyrethroids except tetramethrin
significantly induced CYP3A4 but caused little changes in the expression of carboxylesterases.
Overall, the magnitude of the induction was inversely correlated with the rates of hydrolysis,
but positively correlated with the activation of PXR. Transfection of a carboxylesterase
markedly decreased PXR activation, and the decrease was in agreement with carboxylesterase-
based preference for hydrolysis.
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MATERIALS AND METHODS
Chemicals and supplies
All pyrethroids were purchased from ChemService (West Chester, PA), and the purity and
composition of isomers are listed in Table I. Hanks balanced salt solution, pregnenolone 16α-
carbonitrle (PCN) and William’s medium E (WME) were purchased from Sigma (St. Louis,
MO). Eagle's minimum Essential medium (EMEM) and Insulin-Transferrin-Selenium (ITS)
G supplement were purchased from Invitrogen (Carlsbad, CA). Dual-Luciferase Reporter
Assay System was from Promega (Madison, WI). Fetal bovine serum (FBS) was from HyClone
laboratories (Logan, UT). Taqman probes (Table II) were from Applied Biosystem Incorporate
(Foster City, CA). Microsomes from baculovirus-infected insect cells (Supersomes) co-
expressing CYP3A4/P450 reductase/b5 and control Supersomes were purchased from BD
Biosciences (Woburn, MA). Unless otherwise specified, all other reagents were purchased
from Fisher Scientific (Fair Lawn, NJ).
Hydrolysis of pyrethroids
Hydrolysis of pyrethroids was determined with human liver microsomes (Tang et al., 2006)
and cell lysates containing recombinant HCE1 and HCE2. Lysates were prepared from stable
transfected insect cell lines (Zhu et al., 2000). The abundance of HCE1 or HCE2 in the lysates
was estimated according to immunostaining intensities generated with serial amounts of
purified HCE1 and HCE2. Enzymatic reactions were carried out at 37°C in a total volume of
150 µl. Samples (usually 50 µg protein) were prepared in 75 µl Tris-HCl buffer (50 mM, pH
7.4) and then mixed with an equal volume of a pyrethroid (200 µM) in the same buffer. The
incubations lasted for 20–60 min depending on a pyrethroid, which kept the metabolism in the
linear range. The reactions were terminated with 300 µl of acetonitrile containing naproxen (2
µg/ml) or clopidogrel (16 µg/ml) as the IS (internal standard). The reaction mixtures were
subjected to centrifugation for 15 min at 4°C (15,000 g) to remove proteins.
Metabolism of pyrethroids by recombinant CYP3A4
Oxidation of pyrethroids by CYP3A4 was determined, essentially as described previously
(Yang and Yan, 2007). Preliminary studies were conducted to determine conditions supporting
a linear metabolic rate including the incubation time, the amount of CYP3A4 and the
concentrations of a pyrethroid. The incubation reactions were performed in a total volume of
100 µl. The reaction mixtures contained Supersomes (5 pmol P450) co-expressing P450
reductase and b5, potassium phosphate buffer (50 mM, pH 7.4), MgCl2 (3 mM), EDTA (1
mM), and a pyrethroid (50 µM). Reactions were initiated by the addition of the NADPH-
regenerating system (NRS), consisting of NADP (1 mM), glucose 6-phosphate (1U/ml), and
glucose-6-phosphate dehydrogenase (5 mM), placed in a shaking incubator at 37°C, and
terminated by the addition of 200 µl of acetonitrile after 10 to 60 min depending on a pyrethroid.
Esfenvalerate (4 µg/ml) served as the internal standard for bifenthrin metabolism, whereas
bifenthrin (4 µg/ml) served as the IS for the metabolism of all other pyrethroids. Several
controls were performed including: zero-time incubation, exclusion of the NRS, and
Supersomes expressing no P450. The metabolism was detected only with CYP3A4
Supersomes in the presence of the NRS.
High-performance liquid chromatography (HPLC)
Hydrolysis of pyrethroids was monitored by HPLC (Hitachi LaChrom Elite-300) with a
Chromolith SpeedROD column RP-18e (Merck, Germany). The supernatants (10–30 µl) of
the reaction mixtures were injected and separated by a gradient mobile phase consisting of
acetonitrile and formic acid (0.01%). The gradient was run at 20–50% acetonitrile (v/v) for 6
min, 50–80% for 5 min followed by 80-20% for 6 min. The flow rate was 2 ml/min and
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disappearance of a parent compound was monitored by a diode array detector at 230 nm. Two
injections were made for each sample and all reactions were conducted three times with the
same batch of enzyme preparations. All quantifications were performed using peak area ratios
and calibration curves generated from the corresponding internal control.
Culture and treatment of human primary hepatocytes and cell lines
Plated human primary hepatocytes (in 12-well plate) were obtained from the Liver Tissues
Procurement and Distribution System (University of Minnesota) or commercial sources
(CellzDirect, Pittsboro, NC). Four donors were included with two males (35 and 62 years old)
and two females (39 and 54 years old). Among the donors, three were Caucasian and one Africa
American (the 35-year male). None of them was smoker. Upon arrival, medium was replaced
with rich WME containing ITS supplement and penicillin (100 U/ml)/streptomycin (10 µg/ml)
(Ma et al., 2004). After incubation at 37°C with 5% CO2 for 24 h, hepatocytes were treated
with a pyrethroid (10 µM) for 24 h. Three cell lines were used including hepatoma line HepG2,
lung large cell carcinoma line Hop92 and colorectal adenocarcinoma line LS180. HepG2 and
LS180 were purchased from the American Type Culture Collection (Rockville, MD), whereas
Hop92 was from the National Cancer Institute. The cell lines were cultured in EMEM
supplemented with 10% FBS, penicillin/streptomycin, 1x non-essential amino acids. Cell lines
were usually seeded at a density of 2.5 × 105 cells/well (12-well plates), and treatment
(delipided serum) was performed 12 h after seeding. Similarly to primary hepatocytes, the
treatment lasted for 24 h.
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
Total RNA was isolated with an RNA-Bee (Friendswood, TX) according to the manufacturer’s
manual, and the integrity of the RNA was confirmed by electrophoresis. RNA (1 µg) was
subjected to the synthesis of the first strand cDNA in a total volume of 25 µl with random
primers and M-MLV reverse transcriptase. The reactions were conducted at 25°C for 10 min,
42°C for 50 min and 70°C for 10 min. The cDNAs were then diluted 8 times and RT-qPCR
was conducted with TaqMan Gene Expression Assay (Applied Biosystems, Foster City, CA)
(Yang et al., 2007). The PCR amplification was conducted in a total volume of 20 µl containing
universal PCR master mixture (10 µl), gene-specific TaqMan assay mixture (1 µl), and cDNA
template (6 µl). Cycling profile was 50°C for 2 min, 95°C for 10 min, followed by 40 cycles
of 15 s at 95°C and 1 min at 60 °C, as recommended by the manufacturer. The mRNA levels
were normalized according to the level of GAPDH and RNA polymerase II (selected samples).
Amplification and quantification were done with the Applied Biosystems 7900 Real-Time PCR
System.
Cotransfection and activation of human PXR
The activation of human PXR was performed in a stable line (hPXR-HRE) constitutively
expressing human PXR and harboring a PXR element luciferase reporter (Song et al., 2004).
This line was maintained in EMEM medium supplemented with 10% FBS and antibiotics
(Zeocin, 300 µg/ml; blasticidin, 5 µg/ml). To determine the activation of PXR by pyrethroids,
the hPXR-HRE cells were plated in 96-well plates at 4 × 104/well. After an overnight
incubation, the cells were treated for 24 h with a pyrethroid at 10 µM in 10% delipided FBS
without antibiotics. Cell lysates were then prepared and analyzed for luciferase activity. The
signal was normalized with the amount of protein. To determine the effect of hydrolysis on the
activation of PXR, hPXR-HRE cells were plated in 6-well-paltes and transfected with HCE1,
HCE2 or the corresponding vector (Xie et al., 2002). After a 24-h culturing, the transfected
cells were harvested, combined and plated again in 48-well plates at 8 × 104/well. After another
12-h culturing, the cells were treated with a pyrethroid for 24 h and luciferase activity was
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subsequently determined. It should be noted that no evident changes were observed on the cell
viability with the treatment.
The activation of rat PXR and polymorphic mutants of human PXR was conducted with
cotransfection as described previously (Song et al., 2005; Yang and Yan, 2007). Cells (HepG2)
were plated in 48-well plates in EMEM supplemented with 10% FBS at a density of 6 × 104
cells per well. Transfection was conducted by FuGene HD (Roche, Indianapolis, IN).
Transfection mixtures contained 100 ng of a PXR construct, 50 ng of reporter plasmid
CYP3A4-DP-Luc (Song et al., 2005), and 5 ng of TK-Renilla luciferase plasmid. Cells were
transfected for 12 h and the medium was replaced with fresh medium supplemented with 1%
delipided FBS. The treatment lasted for 24 h and the cells were washed once with phosphate
buffered saline (PBS), lysed by addition of 50 µl of passive lysis buffer with shaking at room
temperature for 30 min. The reporter enzyme activities were assayed with a Dual-Luciferase
Reporter Assay System (Liu et al., 2008). This system contained two substrates, which were
used to determine the activities of two luciferases sequentially. The firefly luciferase activity,
which represented the reporter activity, was initiated by mixing an aliquot of lysates (10 µl)
with Luciferase Assay Reagent II. Then the firefly luminescence was quenched and the
Renilla luminescence was simultaneously activated by adding Stop & Glo Reagent to the
sample tubes. The firefly luminescence signal was normalized based on the Renilla
luminescence signal.
Western analysis
Microsomes or lysates were resolved by 7.5% SDS-PAGE in a mini-gel apparatus and
transferred electrophoretically to nitrocellulose membranes. After non-specific binding sites
were blocked with 5 % non-fat milk, the blots were incubated with an antibody against HCE1,
HCE2, CYP3A4 or GAPDH. The preparation of the antibodies against HCE1, HCE2 or
CYP3A4 was described elsewhere (Zhu et al., 2000; Xie et al., 2002). The primary antibodies
were subsequently localized with goat anti-rabbit IgG conjugated with horseradish peroxidase.
Horseradish peroxidase activity was detected with a chemiluminescent kit (SuperSignal West
Pico). The chemiluminescent signal was captured by KODAK Image Station 2000 and the
relative intensities were quantified by KODAK 1D Image Analysis Software.
Other analyses—Protein concentrations were determined with BCA assay (Pierce) based
on albumin standard. Data are presented as mean ± SD of at least three separate experiments,
except where results of blots are shown in which case a representative experiment is depicted
in the figures. Comparisons between two values were made with Student’s test at p < 0.05.
Correlations analyses were performed with SPSS version 16.
RESULTS
Hydrolysis of a panel of pyrethroids by human liver microsomes
Carboxylesterases play an important role in the metabolism of pyrethroids (Nishi et al.,
2006; Ross et al., 2006). In rodents, it has been shown that hydrolysis offers critical protection
against pyrethroid-induced toxicity (Cantalamessa, 1993). One of the objectives of this study
was to determine whether there is a correlation between hydrolysis of various pyrethroids by
human livers and the toxicity established in animals. Human liver microsomes were pooled
and tested for the hydrolysis of 11 pyrethroids (Table I, Fig. 1). Selection of these pyrethroids
was based on the structural diversity, the extent of use and their relative toxicity in rodents
(Casida et al., 1983; Dich et al., 1997; Table I). These insecticides are currently registered for
use without restriction (EPA, 2008). Some of the pyrethroids were previously studied for
hydrolysis by other investigators (Nishi et al., 2006; Ross et al., 2006). All pyrethroids tested
in this study (Table I) were purchased from ChemService and utilized without further
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purification. The hydrolysis was monitored by HPLC based on the disappearance of parent
compounds. Under the experimental condition, all pyrethroids were eluted with a single peak
except permethrin, baythroid and tetramethrin. Permethrin displayed two peaks with distinct
retention time (RT=10.18, 10.41 min) (Table I). In contrast, baythroid and tetramethrin
produced two peaks, but these peaks were closely overlapped.
The results on the hydrolysis are summarized in Fig. 2. All pyrethroids were hydrolyzed by
human liver microsomes, however, the extent of the hydrolysis varied by as many as 14 fold
(Fig. 2). Bioresmethrin (Bior) was hydrolyzed to the highest extent, whereas bifenthrin (Bif)
to the least. Overall, the insecticides could be divided into three groups based on the rates of
hydrolysis. The group with a high rate included bioallethrin (Bioa), bioresmethrin, deltamethrin
(Del) and tetramethrin (Tet); the group with a moderate rate included baythroid (bay) and
lambda-cyhalothrin (Cyh); the group with a low rate included bifenthrin, esfenvalerate (Esf)
and tau-fluvalinate (Tau) (Fig. 2). The rates of permethrin hydrolysis varied by more than 5
fold depending on an isomer (Fig. 2). The one with an RT of 10.18 min (Per-1) was hydrolyzed
much faster than the one with an RT of 10.41 min (Per-2). As a matter of fact, the former
(Per-1) belonged to the group that was hydrolyzed at a high rate, whereas the later (Per-2)
belonged to the group hydrolyzed at a low rate. Permethrin consisted of 46% cis-isomer and
52% trans-isomer. Based on the peak areas and hydrolytic studies reported by other
investigators (Nishi et al., 2006;Crow et al., 2007), the cis-isomer had an RT of 10.41, whereas
the trans-isomer had an RT of 10.18 min.
Differential hydrolysis of pyrethroids by HCE1 and HCE2
We next tested the inter-individual variability in hydrolyzing pyrethroids. Ten individual
microsomal samples were selected from a total of 19 donors (Shi et al., 2006), and the selection
was based on the relative abundance of carboxylesterases HCE1 and HCE2, two major liver
carboxylesterases (Satoh and Hosokawa, 2006). The study with individual donor samples was
performed on the hydrolysis of bioallethrin. This pyrethroid, compared with others, has the
similar size of the alcohol and acid moieties. The relative sizes of the alcohol and acid moieties
of an ester have been suggested to contribute to selective hydrolysis by carboxylesterases (Shi
et al., 2006). As shown in Fig. 3A, all individual samples hydrolyzed bioallethrin, and the
overall hydrolysis varied by ~2-fold. We next tested whether the variation was correlated with
the abundance of HCE1 or HCE2. The immuno-intensities of HCE1 or HCE2 were analyzed
for the correlation with the hydrolytic rate of bioallethrin obtained by individual donor samples.
As shown in Fig. 3B, the hydrolysis of bioallethrin was correlated much higher with HCE1
than HCE2 (correlation coefficients: 0.7935 versus 0.4519, respectively).
The higher correlation with HCE1 suggests that this carboxylesterase is more active than HCE2
in hydrolyzing bioallethrin. To determine whether pyrethroids are differentially hydrolyzed by
HCE1 and HCE2, recombinant HCE1 and HCE2 were assayed for the hydrolysis of this panel
of pyretrhoids. We previously prepared insect cell lines stably expressing HCE1 or HCE2
(Zhu et al., 2000). Cell lysates were prepared from the respective lines and the abundance of
HCE1 or HCE2 in the lysates was estimated according to immunostaining intensities generated
with serial amounts of purified HCE1 and HCE2. Fig. 3C shows the specific activities of HCE1
and HCE2 toward each pyrethroid. HCE1 preferably hydrolyzed bioallethrin, bioresmethrin,
deltamethrin, esfenvalerate and lambda-cyhalothrin. In contrast, HCE2 preferably hydrolyzed
baythroid, bifenthrin, permethrin, tau-fluvalinate and tetramethrin. The extent of the
preference, however, varied markedly. For example, HCE2 hydrolyzed cis-permethrin (Per-2)
7 times as fast as HCE1, but only 15% faster in hydrolyzing trans-permethrin (Per-1) (Fig.
3C). In addition to the preference for hydrolysis, the overall hydrolytic rates were quite different
from one pyrethroid to another. For example, both bioresmethrin and esfenvalerate were
preferably hydrolyzed by HCE1, but bioresmethrin was hydrolyzed 7 times as fast as
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esfenvalerate (Fig. 3C). It should be noted that lysates from vector transfected line showed no
evident hydrolysis toward the pyrethroids.
Pyrethroids induce CYP3A4 but not carboxylesterases
Some xenobiotics such as anticonvulsant carbamazepine increase their own metabolism
through enzyme induction (Magnusson et al., 2007). Next we tested whether pyrethroids induce
the expression of carboxylesterases. Human primary hepatocytes were treated with a pyrethroid
(10 µM) and the expression of HCE1 and HCE2 was monitored by RT-qPCR with Taqman
probes. In addition to HCE1 and HCE2, the expression of CYP3A4 was also monitored. As
shown in Fig. 4A, little changes (<15%) were detected in the levels of HCE1 or HCE2 mRNA.
However, the level of CYP3A4 mRNA was markedly increased in the hepatocytes treated with
a pyrethroid, and the increase was statistically significant with all pyrethroids except
tetramethrin (Fig. 4A). The maximum induction was 3.5 fold and occurred with lambda-
cyhalothrin. Baythroid, bifenthrin, esfenvalerate and tau-fluvalinate, along with lambda-
cyhalothrin, were relatively stronger CYP3A4 inducers (2.5 fold or higher) (Fig. 4A).
Bioallethrin, bioresmethrin and tetramethrin were relatively weaker inducers, and the
remaining pyrethroids caused moderate induction (Fig. 4A). Consistent with the RT-qPCR
analyses, Western blotting detected a significant increase in CYP3A4 but not HCE1 or HCE2
protein in the hepatocytes treated with lambda-cyhalothrin (Fig. 4B). A slight increase in
CYP3A4 protein was detected in the hepatocytes treated with tetramethrin (Fig. 4B).
We next examined whether the induction occurs in immortalized cell lines including HepG2
(hepatoma), Hop92 (lung carcinoma) and LS180 (colorectal adenocarcinoma). Hop92 and
LS180 Cell were included because ingestion and inhalation are recognized to be two major
routes of exposure to pyrethroids (Leng et al., 1997; Heudorf and Angerer, 2001). The cell
lines were treated with esfenvalerate at 1 µM instead of 10 µM. Similarly, total RNA was
isolated and analyzed for the levels of CYP3A4 mRNA by RT-qPCR. As shown in Fig. 4C,
significant induction of CYP3A4 was detected in all cell lines, and HepG2 cells supported
higher induction than Hop92 or LS180 cells. Next we tested the induction as a function of
various concentrations of esfenvalerate in HepG2 cells. As shown in Fig. 4C, the induction of
CYP3A4 occurred in a concentration-dependent manner. Significant induction was detected
when esfenvalerate was assayed at as low as 0.5 µM (Fig. 4C).
To determine whether induction of CYP3A4 enhances the metabolism of pyrethroids, a
pyrethroid was incubated with Supersomes containing recombinant CYP3A4, P450 reductase
and b5 in the presence of the NRS system. As shown in Fig. 4D, bioallethrin and tetramethrin
were metabolized by CYP3A4 to the greatest extent among the pyrethroids, whereas tau-
fluvalinate was metabolized to the least extent. The remaining pyrethroids were comparably
metabolized by CYP3A4. Several controls were performed including: zero-time incubation,
exclusion of the NRS, and Supersomes expressing no P450. The metabolism was detected only
with CYP3A4 Supersomes in the presence of the NRS. It should be noted that the metabolism
of these pyrethroids by CYP3A4, compared with hydrolysis, is slow, suggesting that hydrolysis
but not oxidation is the major pathway for the metabolism of these pyrethroids in humans.
Activation of PXR by pyrethroids
It is well established that PXR supports induction of CYP3A4 in response to a wide range of
structurally diverse xenobiotics (Lemaire et al., 2004; Urquhart et al., 2007). Next we examined
whether these pyrethroids are PXR activators, and more importantly whether the induction of
CYP3A4 is correlated with the activation of PXR. We previously prepared a stable line
constitutively expressing human PXR and harboring a PXR element reporter (Song et al.,
2004). This line (hPXR-HER) was plated in 96 well-plates and the treatment started with a
pyrethroid when cells reached 80% confluence. The luciferase activity was determined 24 h
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after the treatment and normalized according to protein concentrations. As shown in Fig. 5A,
the activation pattern was generally similar as the induction of CYP3A4 among these
pyrethroids (Fig. 4A). For example, lambda-cyhalothrin (Cyh) was the strongest inducer of
CYP3A4 (Fig. 4A) and activated the PXR the most (Fig. 5A). Conversely, bioallethrin was
one of the weaker inducers (Fig. 4A) and activated PXR with less potency (Fig. 5A).
On the other hand, there were several noticeable differences between CYP3A4 induction and
the PXR activation in terms of the relative potency. For example, tau-fluvalinate and lambda-
cyhalothrin caused a comparable induction (3.2 versus 3.5 fold) (Fig. 4A), whereas lambda-
cyhalothrin was a stronger activator of PXR (6.3 versus 3.5 fold) (Fig. 5A). Actually, lambda-
cyhalothrin caused even higher activation than rifampicin (Rif) (Fig. 4A), a prototypical
activator of human PXR (Chrencik et al., 2005). Another difference between the induction and
activation was observed on tetramethrin. This pyrethroid caused only a minimal induction of
CYP3A4 (Fig. 4A). Surprisingly, a 3.5-fold activation of PXR was detected (Figs. 5A). Such
a large disparity was likely due to the difference in the capacity of hydrolysis between the
hPXR-HER line and primary hepatocytes. The hPXR-HRE line was prepared with 293T cell
and had no detectable hydrolytic activity toward pyrethroids, whereas primary hepatocytes
expressed relatively high levels of carboxylesterases. Therefore, it was hypothesized that
hydrolysis of tetramethrin markedly decreases its potency in PXR activation.
We next tested this hypothesis in cotransfection experiments. hPXR-HRE cells were
transfected again with HCE1, HCE2 or the corresponding vector, and the transfected cells were
tested for the activation of PXR by tetramethrin, lambda-cyhalothrin and deltamethrin.
Inclusion of lambda-cyhalothrin and deltamethrin was designed to specify the isoform-based
hydrolysis in decreased activation of PXR. As shown in Fig. 5B, cotransfection markedly
decreased PXR activation by all three pyrethroids, and the decreases were in agreement with
the isoform-dependent hydrolysis. For example, HCE1, much more active than HCE2 in
hydrolyzing lambda-cyhalothrin and deltamethrin (Fig. 3C), caused much more decreases in
PXR activation by these two pyrethroids (Fig. 5B). Conversely, HCE2, slightly more active
than HCE1 in hydrolyzing tetramethrin (Fig. 3C), decreased more PXR activation than HCE1
(Fig. 5B). This observation was confirmed in a concentration-response experiment (5B).
Tetramethrin at 1 µM caused significant activation of PXR in the cells cotransfected by the
vector, in contrast, as high as 5 µM tetramethrin was required to cause significant activation
in HCE1 co-transfected cells (Fig. 5B). Furthermore, none of the concentrations (even at 10
µM) caused significant activation of PXR in HCE2-cotransfected cells (Fig. 5B). Western
blotting confirmed the expression of HCE1 and HCE2 in respectively transfected cells (Fig.
5).
Activation of human PXR variants and rat PXR by pyrethroids
In humans, there exist several PXR polymorphic variants, and we have shown that some of the
variants differed markedly from the wild-type PXR in responding to 8-methoxypsoralen and
rifampicin (Yang and Yan, 2007). We next examined whether these variants respond
differentially to pyrethroids. Cotransfection was performed with a PXR (wild type or a variant),
a CYP3A4 promoter luciferase reporter (Song et al., 2005), and the Renilla plasmid. Three
pyrethroids were tested including baythroid, esfenvalerate and lambda-cyhalothrin. Selection
of these pyrethroids was based on the following considerations: baythroid was similar as
lambda-cyhalothrin in the hydrolysis by human liver microsomes (Fig. 2), but differed in the
potency of CYP3A4 induction and PXR activation (Fig. 4A and Fig. 5A). However, the
opposite was true between baythroid and esfenvalerate (Fig. 2, Fig. 4A and Fig. 5A). As shown
in Fig. 6A, all PXR variants responded similarly as the wild type PXR with a few exceptions.
In some cases, the altered activation of PXR variants occurred similarly with all three
pyrethroids. For example, variant L412I was activated by all three pyrethroids to a less extent
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than the wild-type PXR (Fig. 6A). In other cases, the magnitude of alteration varied depending
on a pyrehroid. For examples, variant S208F was activated by baythroid to a much higher
extent than the wild-type PXR (10.6 versus 5.7 fold), but no differences were detected in the
activation in response to esfenvalerate or lambda-cyhalothrin (Fig. 6A).
It is well established that certain chemicals activate PXR in a species-dependent manner (Song
et al., 2005). We next examined whether rat PXR is activated differentially from human PXR
by this group of pyrethroids. Likewise, co-transfection was conducted to test this possibility.
As shown in Fig. 6B, all pyrethroids activated rat PXR, but the overall activation varied from
one pyrethroid to another. The highest activation was 4.5 fold and occurred with esfenvalerate
and the lowest was 2.0 fold and occurred with bioallethrin (Fig. 6B). With human PXR, the
lowest activation was 1.5 fold (bioresmethrin), whereas the highest activation was 6.3 fold
(lambda-cyhalothrin) (Fig. 5A). Therefore, the activation of rat PXR varied less than that of
human PXR in response to these pyrethroids. Another noticeable difference regarding PXR
activation was the relative potency between lambda-cyhalothrin and esfenvalerate. The former
was a stronger activator of human PXR (Fig. 5A), whereas the later was a stronger activator
of rat PXR (Fig. 6B). As a matter of fact, esfenvalerate activated rat PXR comparably as PCN,
a prototypical activator of rodent PXR (Fig. 6B) (Song et al., 2005). In addition, bifenthrin and
permethrin, relatively weak activators of human PXR (Fig. 5A), but efficaciously activated rat
PXR (Fig. 6B).
DISCUSSION
Pyrethroids represent the most used insecticides in the world and account for more than one-
third of the insecticide market (Dich et al., 1997). In mammals, these insecticides undergo
hydrolytic and oxidative metabolism, and hydrolysis provides critical protection against
pyrethroid-induced toxicity (Cantalamessa, 1993). In this study, we have shown with a panel
of pyrethroids that the magnitude of the hydrolysis varied by as many as 14 fold in human
livers. Some pyrethroids such as esfenvalerate were hydrolyzed preferably by a
carboxylesterases (e.g., HCE1 or HCE2), whereas others such as trans-permethrin were
comparably hydrolyzed by both enzymes. In human primary hepatocytes, pyrethroids caused
little changes in the expression of carboxylesterases. In contrast, the expression of CYP3A4
was significantly induced. Overall, the induction was positively correlated with the activation
of PXR among pyrethroids. Transfection of a carboxylesterase markedly decreased PXR
activation, and the decrease was in agreement with carboxylesterase-based preference for
hydrolysis.
The isoform-based preference for hydrolysis likely serves as an indicator for the magnitude of
the hydrolysis in the liver. HCE1 is a more abundant carboxylesterase than HCE2 in the liver,
thus pyrethroids preferably hydrolyzed by HCE1 were generally hydrolyzed faster by liver
microsomes (Fig. 2 and Fig. 3C). For example, bioallethrin, bioresmethrin and deltamethrin,
preferable substrates of HCE1 (Fig. 3C), were all hydrolyzed efficaciously by liver microsomes
(Fig. 2). Another indicator for the magnitude of hydrolysis is the Type of a pyrethroid. As a
matter of fact, the Type of pyrethroids probably serves a better indicator for the overall
hydrolysis in the liver. With only one exception (deltamethrin), all pyrethroids hydrolyzed at
high rates by liver microsomes are Type I compounds (Table I, Fig. 1 and Fig. 2). Conversely,
the majority of the pyrethroids hydrolyzed at lower rates belong to Type II compounds (e.g.,
tau-fluvalinate) (Table I, Fig. 1 and Fig. 2). An interesting exception was bifenthrin, which is
a Type I compound but was hydrolyzed the least by liver microsomes among all pyrethroids
tested (Fig. 1 and Fig. 2). It has been suggested that the poor hydrolysis of this pyrethroid is
due to the rigidity of the acid moiety (a methyl biphenyl group) (Nishi et al., 2006). In this
study, we have shown that lambda-cyhalothrin, with the same alcohol moiety (cyano-3-
phenoxybenzyl group) as bifenthrin (Fig. 1), was hydrolyzed at a moderate rate (Fig. 2),
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suggesting that the alcohol moiety, like the acid moiety, also contributes to the less effective
hydrolysis.
The relative size of the acid and alcohol moieties of an ester has been suggested to be a factor
for the hydrolytic preference between HCE1 and HCE2. This principle, however, does not
quite apply to pyrethroids. Bioresmethrin, for example, has an acid moiety with a comparable
size as the alcohol moiety (162 versus 174, Fig. 1), but was hydrolyzed overwhelmingly by
HCE1 (Fig. 3C). Pyrethroids are highly lipophilic, and the selective hydrolysis of such
lipophilic substrates likely depends on the overall configuration other than the relative sizes
between the acid and alcohol moieties. It should be noted that there are conflicting reports on
the selective hydrolysis of deltamethrin. This study and a previous report by Godin et al.
(2006) showed that deltamethrin was preferably hydrolyzed by HCE1. However, Nishi et al.
(2006) reported that this pyrethroid was a better substrate of HCE2. All three studies were
performed in Tris-HCl buffer, but the study by Nichi et al used higher pH (8.0 versus 7.4). It
is likely that HCE2 works better at higher pH, particularly with lipophilic substrates.
The magnitude of hydrolysis likely determines the overall toxicity of pyrethroids, particularly
the lethal potency. Table I shows the LD50 values for these compounds in rats, ranging from
26 mg/kg (tau-fluvalinate) to 4640 mg/kg (tetramethrin). Consistent with such a large
difference in the LD50 values, tetramethrin was hydrolyzed 9 times as fast as tau-fluvalinate
by human liver microsomes (Fig. 2). These findings suggest that these pyrethroids are
hydrolyzed comparably in both humans and rats. While the hydrolytic rates are generally
correlated with their LD50 values, there were notable exceptions. For example, bioallethrin
was hydrolyzed 8 times as fast as bifenthrin (Fig. 2), however, bifenthrin is less toxic than
bioallethrin based on the LD50 values (545 versus 425 mg/kg, Table I). It is likely that bifenthrin
is effectively hydrolyzed by rat carboxylesterases. Alternatively, other metabolic pathways
such as oxidation contribute significantly to the detoxication of bifenthrin in rats.
The activation potential of PXR, along with the magnitude of hydrolysis, appears to play
determinant roles in CYP3A4 induction. Bioallethrin, bioresmethrin and tetramethrin were
rapidly hydrolyzed, thus caused the least induction of CYP3A4 among the pyrethroids (Fig.
2, Fig. 3C and Fig. 4A). In contrast, lambda-cyhalothrin and tau-fluvalinate were hydrolyzed
to a much less extent, thus caused much higher induction (Fig. 2 and Fig. 4A). On the other
hand, baythroid was hydrolyzed 3 times as fast as bifenthrin and yet caused higher induction
of CYP3A4 (Fig. 2, Fig. 3C and Fig. 4A). Such discrepancy was likely due to their difference
in the potency of PXR activation. Indeed, bifenthrin was a much weaker PXR activator than
baythroid (1.7 versus 3.3, Fig. 5A). It should be noted that the activation of human PXR was
performed in the hPXR-HRE line, and this line showed no detectable hydrolytic activity toward
pyrethroids.
The cotransfection of the hPXR-HRE line by a carboxylesterases provided a nice illustration
on how hydrolysis and activation of PXR coordinate in the induction of CYP3A4. In primary
hepatocytes, tetramethrin was the weakest CYP3A4 inducer (Fig. 4A). This pyrethroid,
however, was one of the stronger PXR activators in the hPXR-HRE line (Fig. 5A). The
efficacious activation of PXR by tetramethrin was markedly decreased by HCE1 or HCE2
cotransfection (Fig. 5B). The decrease was higher by HCE2 than HCE1, consistent with the
observation that HCE2 hydrolyzed tetramethrin at a slightly higher rate than HCE1 (Fig. 3C).
The importance of the hydrolysis in PXR activation likely provides a molecular basis for
pesticide-pesticide interaction, particularly between pyrethroids and organophosphates.
Organophosphates irreversibly inhibit carboxylesterases (Pope et al., 2005) and presumably
decrease the hydrolysis of pyrethroids. Therefore, combined use of a pyrethroid and an
organophosphate could increase the potential of pyrethroids in PXR activation and CYP
induction.
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The efficacious activation of PXR by some of the pyrethroids ranks these chemicals as one of
the most potent classes of PXR activators. In this study, we have shown that lambda-cyhalothrin
caused even higher activation of human PXR than rifampicin (Fig. 5A), a prototypical activator
of human PXR (Chrencik et al., 2005). Interestingly, with only a single exception of
tetramethrin, pyrethroids with higher PXR activation activity all belong to Type II pyrethroids,
suggesting that the cyano moiety facilitates interaction with PXR. In addition, the Type II
pyrethroids all contain a phenoxybenzyl group (Fig. 1), which, along with the cyano moiety,
forms a bulky and lipophilic platform. Such structure presumably increases the specificity to
interact with the ligand binding pocket of PXR. In addition, these chemicals differentially
activated certain polymorphic variants of human PXR (Fig. 6A). For example, PXR variant
S208F was activated much higher than the wild type PXR (10.6 versus 5.7 fold) (Fig. 6A).
Likewise, significant difference in the activation of human and rat PXR was detected on the
relative potency between lambda-cyhalothrin and esfenvalerate. Lambda-cyhalothrin was a
stronger activator of human PXR, whereas esfenvalerate was a stronger activator of rat PXR
(Fig. 5A and Fig. 6B). Likewise, bifenthrin and permethrin were relatively weak activators of
human PXR (Fig. 5A) but efficaciously activated rat PXR (Fig. 6B). These findings suggest
that induction of PXR target genes by pyrethroids occur in a species- and polymorphism-
dependent manner.
The activation of PXR by pyrethroids likely contributes significantly to their toxicity,
particularly related to chronic exposure. In addition to neurotoxicity, pyrethroids are
increasingly linked to other organ toxicities such as reproduction (Perry et al., 2007). The
reproductive toxicity is likely due to their partial antagonistic activity toward the estrogen or
androgen receptors (Chen et al., 2002; Sun et al., 2007). On the other hand, hormones such as
testosterones are metabolized by CYP enzymes (Choi et el., 2005). In this study, we have shown
that esfenvalerate at 0.5 µM significantly induced CYP3A4 (Fig. 4C). Therefore, induction of
enzymes that metabolize hormones likely serves as an alternative mechanism for pyrethroids-
induced reproductive toxicity. As a class of the most used insecticides in the world, both the
general population and workers have a potential of high exposure to these insecticides.
Epidemiological studies have shown that the exposure level, in some cases, can be high (Leng
et al., 1997; Heudorf and Angerer, 2001). The concentrations of pyrethroid metabolites in the
urine are usually monitored as a marker for exposure. Given the fact that pyrethroids undergo
metabolism and not all pyrethroids in the body are eliminated through the urine (Leng et al.,
1997; Anand et al., 2006; Godin et al., 2007), the urinary metabolites-based estimation is likely
lower than the actual exposure level. Furthermore, the local concentrations in the entries such
as the skin and the lung can be considerably higher even than the corresponding blood
concentrations of exposed pyrethroids.
In summary, our work points to several important conclusions. First, the overall hydrolysis by
liver microsomes varies depending on the Type of pyrethroids and the isoform-preference for
hydrolysis. Given the observation that hydrolysis provides critical protection against
pyrethroids-induced toxicity, the Type of pyrethroids and the preference for hydrolysis likely
serve as indicators for toxicological predication in humans. Second, significant induction of
CYP3A4 is detected at sub-micromolar concentrations of pyrethroids, providing a sensitive
biomarker for pyrethroid exposure. Third, the induction of CYP3A4 is correlated positively
with the activation of PXR and the activation varies between human and rat PXRs as well as
among human PXR polymorphic variants, suggesting that induction of PXR target genes by
pyrethroids occurs in a polymorphism and species-dependent manner.
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Fig. 1. Chemical structure of pyrethroids
Based on the absence or presence of the cyano moiety in the α-position, a chemical with the
cyano moiety is labeled as Type II, whereas a chemical without this moiety is labeled as Type
I pyrethroid.
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Fig. 2. Hydrolysis of pyrethroids by pooled human liver microsomes
Samples (50 µg protein) were prepared in 75 µl Tris-HCl buffer (50 mM, pH 7.4) and then
mixed with an equal volume of a pyrethroid (200 µM) in the same buffer. The incubations
lasted for 30–60 min depending on a pyrethroid and the reactions were terminated with 300 µl
of acetonitrile containing naproxen (2 µg/ml) or clopidogrel (16 µg/ml) as the IS. The reaction
mixtures were subjected to centrifugation for 15 min at 4°C (15,000 g) to remove proteins. The
hydrolysis of pyrethroids was monitored by HPLC as described in the section of Materials and
Methods. Hydrolytic rates were expressed as the mean ± SD (nmol/mg/min) from three
independent experiments.
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Fig. 3. Isoform-specific hydrolysis of pyrethroids
(A) Hydrolysis of bioallethrin by individual donor samples Enzymatic reactions were set up
with 50 µg microsomal protein and 100 µM bioallethrin. The reactions lasted for 30 min and
the hydrolysis of bioallethrin was monitored by HPLC. For Western blots, samples (1 µg) were
subjected to SDS-PAGE and transferred electrophoretically to a Trans-Blot nitrocellulose
membrane. The immunoblots were incubated with the antibody (10 µg/ml) against HCE1,
HCE2 or GAPDH and detected by horseradish peroxidase- conjugated anti-rabbit IgG and a
chemiluminescent kit. The immunostaining intensity was quantified by KODAK 1D Image
Analysis Software. (B) Correlation analysis of bioallethrin hydrolysis with HCE1 or HCE2
The hydrolysis of bioallethrin by individual donor samples was plotted against the
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corresponding immunointensity of HCE1 or HCE2. (C) Hydrolysis of pyrethroids by
recombinant HCE1 or HCE2 Enzymatic reactions were set up as described in the legend of
Fig. 1 but insect cell lysates from HCE1 or HCE2 stable lines were used. The hydrolytic rates
were calculated according to the estimated HCE1 or HCE2 in the lysates.
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Fig. 4. Effect of pyrethroids on the levels of HCE1, HCE2, and CYP3A4 mRNA in primary
hepatocytes or cell lines
(A) Effect of pyrethroids on the levels of HCE1, HCE2, and CYP3A4 mRNA in primary
hepatocytes Human primary hepatocytes were treated with a pyrethroid (10 µM) or the same
volume of vehicle DMSO for 24 h. Total RNAs were isolated and subjected to RT-qPCR
analysis for the level of HCE1, HCE2, or CYP3A4 mRNA by TaqMan probes as described
under Materials and Methods. The signals from each target were normalized based on the signal
from GADPH, and data are expressed as mean ± S.D. of four donors. (B) Western analysis for
the expression of HCE1, HCE2 or CYP3A4 Lysates (5 µg) from hepatocytes treated with
DMSO, lambda-cyhalothrin (Cyh) or tetramethrin (Tet) were SDS-PAGE and transferred
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electrophoretically to a Trans-Blot nitrocellulose membrane. The immunoblots were incubated
with the antibody (10 µg/ml) against HCE1, HCE2 or CYP3A4 and detected by horseradish
peroxidase- conjugated anti-rabbit IgG and a chemiluminescent kit. The immunostaining
intensity was quantified by KODAK 1D Image Analysis Software. (C) Effect of esfenvalerate
on the level of CYP3A4 mRNA in HepG2, Hop92 and LS180 cell lines Cells at 80% confluence
were treated with esfenvalerate (1 µM) for 24 h. Total RNA was isolated and analyzed for the
level of CYP3A4 mRNA by RT-qPCR. The mRNA levels were expressed relatively to those
in control cells (considered as 1). To determine the concentrations-dependent induction, HepG2
cells were plated and treated with esfenvalerate at various concentrations (0–10 µM). After
24-h, total RNA was isolated and analyzed for the level of CYP3A4 mRNA. The DMSO control
is labeled as 0.01 µM to accommodate logarithmic conversions of the data. *Statistically
significant from vehicle control (p < 0.05). (D) Metabolism of pyrethroids by CYP3A4 The
incubation reactions were performed in a total volume of 100 µl. The reaction mixtures
contained Supersomes (5 pmol P450) co-expressing P450 reductase and b5, potassium
phosphate buffer (50 mM, pH 7.4), MgCl2 (3 mM), EDTA(1 mM), and a pyrethroid (50 µM).
Reactions were initiated by the addition of the NRS, placed in a shaking incubator at 37°C,
and terminated by the addition of 200 µl of acetonitrile containing appropriate IS after 10 to
60 min depending on a pyrethroid. The reaction mixtures were subjected to centrifugation for
15 min at 4°C (15,000 g) to remove proteins. The oxidation of pyrethroids was monitored by
HPLC as described in the section of Materials and Methods. The rates were expressed as the
mean ± SD (pmol/pmol P450/min) from three independent experiments.
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Fig. 5. Activation of human PXR and effect of carboxylesterase on the activation
(A) Activation of the chromatinized CYP3A4-ER6 reporter by pyrethroids A stable transfected
line (hPXR-HRE) constitutively expressing human PXR and harboring a PXR element reporter
was seeded in 96-well plates in DMEM supplemented with 10% delipided FBS. After 12-h,
cells (~80% confluence) were treated for 24 h with a pyrethroid (10 µM) or the same volume
of DMSO. Cells were harvested in passive lysis buffer and lysates (10 µl) were assayed for
firefly luciferase activity. The luminescence signal was normalized based on the amount of
protein, and the ratio of a pyrethroid over DMSO treatment served as fold induction. (B) Effect
of carboxylesterase on PXR activation The hPXR-HRE cells were transfected again with
HCE1, HCE2 or the corresponding vector. The transfected cells were then harvested and re-
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plated in 48-well plates at 8 × 104/well. After an overnight incubation, cells were treated with
lambda-cyhalothrin (10 µM), deltamethrin (10 µM) or tetramethrin (0.5, 1, 2, 5 and 10 µM)
or the same volume of DMSO. Lysates were prepared and analyzed for luciferase activity as
described above. To accommodate logarithmic conversions of the data on the concentration-
dependent activation by tetramethrin, the DMSO control is labeled as 0.1 µM. Western blotting
was performed with lysates (1 µg) from carboxylesterase or vector transfected cells.
*Statistically significant from vehicle control (p < 0.05). The data in this figure were assembled
from three separate experiments.
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Fig. 6. Activation of human PXR variants or rat PXR
(A) Activation of human PXR variants by pyrethroids HepG2 cells were plated in 48-well plates
in DMEM supplemented with 10% fetal bovine serum at a density of 6 × 104 cells per well.
Transfection was conducted by FuGene HD after the cells reached 80% confluence. The
transfection mixtures contained 100 ng of a PXR construct, 50 ng of reporter plasmid CYP3A4-
DP-Luc, and 5 ng of TK-Renilla luciferase plasmid. The transfected cells were treated with a
pyrethroid at 10 µM for 24 h. Luciferase activities were determined with a dual luciferase kit.
(B) Activation of rat PXR by pyrethroids The experimental procedure was the same as described
above but a human PXR construct was replaced with rat PXR construct (Zhang et al., 1999).
The data in this figure were assembled from three separate experiments.
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Table I
Purity and retention time of pyrethroids
Pyrethroid Purity Type RT (min)a LD50 (mg/kg)
b
Baythroid (Bay) 98% d II 9.97c 900
Bifenthrin (Bif) 97.2% cis-2.5% trans I 11.03 545
Bioallethrin (Bioa) 3% cis-96% trans I 9.93 425
Bioresmethrin (Bior) 3% cis-96% trans I 9.98 1244
Deltamethrin (Del) 99% II 10.01 535
Esfenvalerate (Esf) 99.5% d II 10.09 325
lambda-Cyhalothrin (Cyh) 99% d II 9.97 56
Permethrin (Per) 46% cis-52% trans I 10.18, 10.41 383
tau-Fluvalinate (Tau) 95%d II 10.41 26
Tetramethrin (Tet) 99% d I 8.72 c 4640
a
Retention time
b
the median lethal dose (oral in rats or mice)
c
with overlapping peaks
d
mix of chiral isomers with one isomer being 90% or higher.
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Table II
Gene, Taqman probe and accession number
Gene Assay identification Accession number
Carboxylesterase-1 (HCE-1) Hs00275607_m1 NM_001266
Carboxylesterases-2 (HCE-2) Hs00187279_m1 NM_198061
Cytochrome P450 3A4 (CYP3A4) Hs00604506_m1 NM_017460
Glyceradehyde-3-phosphate dehydrogenase (GAPDH) 4352934E NM_002046
Polymerase (RNA) II polypeptide A (PoII) Hs01108291_m1 NM_000937
Pregnane X receptor (PXR) Hs00243666_m1 NM_033013
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